Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 330

1.

Systematic review of carbapenem-resistant Enterobacteriaceae causing neonatal sepsis in China.

Ding Y, Wang Y, Hsia Y, Sharland M, Heath PT.

Ann Clin Microbiol Antimicrob. 2019 Nov 14;18(1):36. doi: 10.1186/s12941-019-0334-9.

PMID:
31727088
2.

Antimicrobial Resistance Following Azithromycin Mass Drug Administration: Potential Surveillance Strategies to Assess Public Health Impact.

Mack I, Sharland M, Berkley JA, Klein N, Malhotra-Kumar S, Bielicki J.

Clin Infect Dis. 2019 Oct 21. pii: ciz893. doi: 10.1093/cid/ciz893. [Epub ahead of print]

PMID:
31633161
3.

Antibiotic prescriptions in Italian hospitalised children after serial point prevalence surveys (or pointless prevalence surveys): has anything actually changed over the years?

Tersigni C, Montagnani C, D'Argenio P, Duse M, Esposito S, Hsia Y, Sharland M, Galli L.

Ital J Pediatr. 2019 Oct 17;45(1):127. doi: 10.1186/s13052-019-0722-y.

4.

Aetiology of invasive bacterial infection and antimicrobial resistance in neonates in sub-Saharan Africa: a systematic review and meta-analysis in line with the STROBE-NI reporting guidelines.

Okomo U, Akpalu ENK, Le Doare K, Roca A, Cousens S, Jarde A, Sharland M, Kampmann B, Lawn JE.

Lancet Infect Dis. 2019 Nov;19(11):1219-1234. doi: 10.1016/S1473-3099(19)30414-1. Epub 2019 Sep 12.

PMID:
31522858
5.

High rates of admission in lower middle-income countries' neonatal units suggest an enhanced focus on infection prevention and control measures is required.

Cook A, Lundin R, Bielicki J, Sharland M, Hsia Y.

Arch Dis Child. 2019 Aug 28. pii: archdischild-2019-317318. doi: 10.1136/archdischild-2019-317318. [Epub ahead of print] No abstract available.

PMID:
31462432
6.

Towards understanding global patterns of antimicrobial use and resistance in neonatal sepsis: insights from the NeoAMR network.

Li G, Bielicki JA, Ahmed ASMNU, Islam MS, Berezin EN, Gallacci CB, Guinsburg R, da Silva Figueiredo CE, Santarone Vieira R, Silva AR, Teixeira C, Turner P, Nhan L, Orrego J, Pérez PM, Qi L, Papaevangelou V, Triantafyllidou P, Iosifidis E, Roilides E, Sarafidis K, Jinka DR, Nayakanti RR, Kumar P, Gautam V, Prakash V, Seeralar A, Murki S, Kandraju H, Singh S, Kumar A, Lewis L, Pukayastha J, Nangia S, K N Y, Chaurasia S, Chellani H, Obaro S, Dramowski A, Bekker A, Whitelaw A, Thomas R, Velaphi SC, Ballot DE, Nana T, Reubenson G, Fredericks J, Anugulruengkitt S, Sirisub A, Wong P, Lochindarat S, Boonkasidecha S, Preedisripipat K, Cressey TR, Paopongsawan P, Lumbiganon P, Pongpanut D, Sukrakanchana PO, Musoke P, Olson L, Larsson M, Heath PT, Sharland M.

Arch Dis Child. 2019 Aug 24. pii: archdischild-2019-316816. doi: 10.1136/archdischild-2019-316816. [Epub ahead of print]

PMID:
31446393
7.

Global Divergence From World Health Organization Treatment Guidelines for Neonatal and Pediatric Sepsis.

Jackson C, Hsia Y, Basmaci R, Bielicki J, Heath PT, Versporten A, Goossens H, Sharland M.

Pediatr Infect Dis J. 2019 Nov;38(11):1104-1106. doi: 10.1097/INF.0000000000002433.

PMID:
31425329
8.

Adaptation of the WHO Essential Medicines List for national antibiotic stewardship policy in England: being AWaRe.

Budd E, Cramp E, Sharland M, Hand K, Howard P, Wilson P, Wilcox M, Muller-Pebody B, Hopkins S.

J Antimicrob Chemother. 2019 Nov 1;74(11):3384-3389. doi: 10.1093/jac/dkz321.

9.

Implementation of a Highly Accurate Rapid Point-of-Care Test for Group a Streptococcus Detection at a Large Pediatric Emergency Department in South London.

Demirjian A, Bustinduy AL, Ladhani S, Iqbal Y, Sharland M.

Pediatr Infect Dis J. 2019 Aug;38(8):e183-e185. doi: 10.1097/INF.0000000000002284.

PMID:
31310596
10.

Antibiotic Review Kit for Hospitals (ARK-Hospital): study protocol for a stepped-wedge cluster-randomised controlled trial.

Walker AS, Budgell E, Laskawiec-Szkonter M, Sivyer K, Wordsworth S, Quaddy J, Santillo M, Krusche A, Roope LSJ, Bright N, Mowbray F, Jones N, Hand K, Rahman N, Dobson M, Hedley E, Crook D, Sharland M, Roseveare C, Hobbs FDR, Butler C, Vaughan L, Hopkins S, Yardley L, Peto TEA, Llewelyn MJ; ARK trial team.

Trials. 2019 Jul 11;20(1):421. doi: 10.1186/s13063-019-3497-y.

11.

Strategic Trials to Define the Best Available Treatment for Neonatal and Pediatric Sepsis Caused by Carbapenem-resistant Organisms.

Donà D, Sharland M, Heath PT, Folgori L.

Pediatr Infect Dis J. 2019 Aug;38(8):825-827. doi: 10.1097/INF.0000000000002381.

PMID:
31261359
12.

Essential and forgotten antibiotics: An inventory in low- and middle-income countries.

Tebano G, Li G, Beovic B, Bielicki J, Brink A, Enani MA, Godman B, Hinrichsen SL, Kibuule D, Gabriel LH, Oduyebo O, Sharland M, Singh S, Wertheim HFL, Nathwani D, Pulcini C; European Society of Clinical Microbiology and Infectious Diseases Study Group for Antimicrobial Stewardship.

Int J Antimicrob Agents. 2019 Sep;54(3):273-282. doi: 10.1016/j.ijantimicag.2019.06.017. Epub 2019 Jun 28.

PMID:
31260741
13.

Management of Invasive Fungal Disease in Neonates and Children.

Ferreras-Antolín L, Sharland M, Warris A.

Pediatr Infect Dis J. 2019 Jun;38(6S Suppl 1):S2-S6. doi: 10.1097/INF.0000000000002317.

PMID:
31205236
14.

Use of the WHO Access, Watch, and Reserve classification to define patterns of hospital antibiotic use (AWaRe): an analysis of paediatric survey data from 56 countries.

Hsia Y, Lee BR, Versporten A, Yang Y, Bielicki J, Jackson C, Newland J, Goossens H, Magrini N, Sharland M; GARPEC and Global-PPS networks.

Lancet Glob Health. 2019 Jul;7(7):e861-e871. doi: 10.1016/S2214-109X(19)30071-3.

15.

Safety and Efficacy of Tigecycline to Treat Multidrug-resistant Infections in Pediatrics: An Evidence Synthesis.

Sharland M, Rodvold KA, Tucker HR, Baillon-Plot N, Tawadrous M, Hickman MA, Raber S, Korth-Bradley JM, Díaz-Ponce H, Wible M.

Pediatr Infect Dis J. 2019 Jul;38(7):710-715. doi: 10.1097/INF.0000000000002339.

PMID:
31192975
16.

Efficacy, safety and impact on antimicrobial resistance of duration and dose of amoxicillin treatment for young children with Community-Acquired Pneumonia: a protocol for a randomIsed controlled Trial (CAP-IT).

Lyttle MD, Bielicki JA, Barratt S, Dunn D, Finn A, Harper L, Jackson P, Powell CVE, Roland D, Stohr W, Sturgeon K, Wan M, Little P, Faust SN, Robotham J, Hay AD, Gibb DM, Sharland M; PERUKI, GAPRUKI and the CAP-IT trial team.

BMJ Open. 2019 May 22;9(5):e029875. doi: 10.1136/bmjopen-2019-029875.

17.

Hard to study, hard to treat: putting children at the centre of antibiotic research and development.

Balasegaram M, Pécoul B, Gray G, Sharland M, Swaminathan S.

Lancet Infect Dis. 2019 Jun;19(6):573-574. doi: 10.1016/S1473-3099(19)30214-2. No abstract available.

PMID:
31122767
18.

Population pharmacokinetic meta-analysis of individual data to design the first randomized efficacy trial of vancomycin in neonates and young infants.

Jacqz-Aigrain E, Leroux S, Thomson AH, Allegaert K, Capparelli EV, Biran V, Simon N, Meibohm B, Lo YL, Marques R, Peris JE, Lutsar I, Saito J, Nakamura H, van den Anker JN, Sharland M, Zhao W.

J Antimicrob Chemother. 2019 Aug 1;74(8):2128-2138. doi: 10.1093/jac/dkz158.

PMID:
31049551
19.

Early origins of oral penicillin dosing for children.

Sharland E, Long P, Sharland M, Bielicki J, Saxena S, Wong ICK, Barker C.

Arch Dis Child. 2019 Apr 17. pii: archdischild-2018-316531. doi: 10.1136/archdischild-2018-316531. [Epub ahead of print] No abstract available.

20.

The potential of fosfomycin for multi-drug resistant sepsis: an analysis of in vitro activity against invasive paediatric Gram-negative bacteria.

Williams PCM, Waichungo J, Gordon NC, Sharland M, Murunga S, Kamau A, Berkley JA.

J Med Microbiol. 2019 May;68(5):711-719. doi: 10.1099/jmm.0.000973. Epub 2019 Apr 17.

PMID:
30994430
21.

All-cause pneumonia in children after the introduction of pneumococcal vaccines in the United Kingdom: A population-based study.

Lau WCY, Bielicki J, Tersigni C, Saxena S, Wong ICK, Sharland M, Hsia Y.

Pharmacoepidemiol Drug Saf. 2019 Jun;28(6):821-829. doi: 10.1002/pds.4770. Epub 2019 Apr 16.

PMID:
30993835
22.

Estimating global trends in total and childhood antibiotic consumption, 2011-2015.

Jackson C, Hsia Y, Bielicki JA, Ellis S, Stephens P, Wong ICK, Sharland M.

BMJ Glob Health. 2019 Feb 27;4(1):e001241. doi: 10.1136/bmjgh-2018-001241. eCollection 2019.

23.

Pattern of Antimicrobial Resistance in Bloodstream Isolates From Chinese Neonates.

Zhang J, Folgori L, Hsia Y, Sharland M, Yang Y.

Pediatr Infect Dis J. 2019 Jun;38(6):600-604. doi: 10.1097/INF.0000000000002246. No abstract available.

PMID:
30672894
24.

Neonatal sepsis in South Asia: huge burden and spiralling antimicrobial resistance.

Chaurasia S, Sivanandan S, Agarwal R, Ellis S, Sharland M, Sankar MJ.

BMJ. 2019 Jan 22;364:k5314. doi: 10.1136/bmj.k5314. Review. No abstract available.

25.

The use of polymyxins to treat carbapenem resistant infections in neonates and children.

Thomas R, Velaphi S, Ellis S, Walker AS, Standing JF, Heath P, Sharland M, Dona' D.

Expert Opin Pharmacother. 2019 Mar;20(4):415-422. doi: 10.1080/14656566.2018.1559817. Epub 2018 Dec 21. Review.

PMID:
30576264
26.

Correction to: Pharmacokinetic-Pharmacodynamic Modeling in Pediatric Drug Development, and the Importance of Standardized Scaling of Clearance.

Germovsek E, Barker CIS, Sharland M, Standing JF.

Clin Pharmacokinet. 2019 Jan;58(1):139. doi: 10.1007/s40262-018-0723-9.

27.

Consumption of oral antibiotic formulations for young children according to the WHO Access, Watch, Reserve (AWaRe) antibiotic groups: an analysis of sales data from 70 middle-income and high-income countries.

Hsia Y, Sharland M, Jackson C, Wong ICK, Magrini N, Bielicki JA.

Lancet Infect Dis. 2019 Jan;19(1):67-75. doi: 10.1016/S1473-3099(18)30547-4. Epub 2018 Dec 3.

PMID:
30522834
28.

Enterovirus and parechovirus meningitis in infants younger than 90 days old in the UK and Republic of Ireland: a British Paediatric Surveillance Unit study.

Kadambari S, Braccio S, Ribeiro S, Allen DJ, Pebody R, Brown D, Cunney R, Sharland M, Ladhani S.

Arch Dis Child. 2019 Jun;104(6):552-557. doi: 10.1136/archdischild-2018-315643. Epub 2018 Dec 8.

29.

Antibiotics and Cure Rates in Childhood Febrile Urinary Tract Infections in Clinical Trials: A Systematic Review and Meta-analysis.

Vazouras K, Basmaci R, Bielicki J, Folgori L, Zaoutis T, Sharland M, Hsia Y.

Drugs. 2018 Oct;78(15):1593-1604. doi: 10.1007/s40265-018-0988-1.

30.

World Society for Pediatric Infectious Diseases declaration on combating antimicrobial resistance in children.

Buttery J, Yang Y, Sharland M; World Society for Pediatric Infectious Diseases.

World J Pediatr. 2018 Dec;14(6):523-524. doi: 10.1007/s12519-018-0195-x. Epub 2018 Oct 5. No abstract available.

PMID:
30291520
31.

Priority Needs for Conducting Pandemic-relevant Clinical Research With Children in Europe: A Consensus Study With Pediatric Clinician-researchers.

Gal M, Gobat N, Francis NA, Hood K, Butler CC, Bielicki J, Fraaij PL, Sharland M, Jarvis J, van Rossum AMC, Heikkinen T, Martinon-Torres F, Herberg J, Watkins A, Webb SAR, Moore R, Sukumar P, Nichol A.

Pediatr Infect Dis J. 2019 May;38(5):e82-e86. doi: 10.1097/INF.0000000000002204.

32.

Scaling beta-lactam antimicrobial pharmacokinetics from early life to old age.

Lonsdale DO, Baker EH, Kipper K, Barker C, Philips B, Rhodes A, Sharland M, Standing JF.

Br J Clin Pharmacol. 2019 Feb;85(2):316-346. doi: 10.1111/bcp.13756. Epub 2018 Nov 26.

PMID:
30176176
33.

Management of children with multidrug-resistant sepsis in low-income and middle-income countries.

Basmaci R, Bielicki J, Daniels R, Kissoon N, Ellis S, Balasegaram M, Sharland M.

Lancet Child Adolesc Health. 2018 Jan;2(1):8-10. doi: 10.1016/S2352-4642(17)30153-0. Epub 2017 Nov 28. No abstract available.

PMID:
30169199
34.

Interventions to prevent urinary catheter-associated infections in children and neonates: a systematic review.

Araujo da Silva AR, Marques AF, Biscaia di Biase C, Zingg W, Dramowski A, Sharland M.

J Pediatr Urol. 2018 Dec;14(6):556.e1-556.e9. doi: 10.1016/j.jpurol.2018.07.011. Epub 2018 Jul 21.

PMID:
30126746
35.

Clinical Photography: A Self Help Guide.

Sharland M.

Prim Dent J. Summer 2018;7(2):36-9. No abstract available.

PMID:
30095880
36.

Antibiotic usage in Chinese children: a point prevalence survey.

Zhang JS, Liu G, Zhang WS, Shi HY, Lu G, Zhao CA, Li CC, Li YQ, Shao YN, Tian DY, Ding MJ, Li CY, Luo LJ, Dong XY, Jin P, Wang P, Zhu CM, Wang CQ, Zheng YJ, Deng JK, Sharland M, Hsia YF, Shen KL, Yang YH.

World J Pediatr. 2018 Aug;14(4):335-343. doi: 10.1007/s12519-018-0176-0. Epub 2018 Jul 30.

PMID:
30062648
37.

Using risk adjustment to improve the interpretation of global inpatient pediatric antibiotic prescribing.

Bielicki JA, Sharland M, Versporten A, Goossens H, Cromwell DA.

PLoS One. 2018 Jul 6;13(7):e0199878. doi: 10.1371/journal.pone.0199878. eCollection 2018.

38.

Antibiotic use for community-acquired pneumonia in neonates and children: WHO evidence review.

Mathur S, Fuchs A, Bielicki J, Van Den Anker J, Sharland M.

Paediatr Int Child Health. 2018 Nov;38(sup1):S66-S75. doi: 10.1080/20469047.2017.1409455.

39.

Reviewing the WHO guidelines for antibiotic use for sepsis in neonates and children.

Fuchs A, Bielicki J, Mathur S, Sharland M, Van Den Anker JN.

Paediatr Int Child Health. 2018 Nov;38(sup1):S3-S15. doi: 10.1080/20469047.2017.1408738.

40.

Plasma and CSF pharmacokinetics of meropenem in neonates and young infants: results from the NeoMero studies.

Germovsek E, Lutsar I, Kipper K, Karlsson MO, Planche T, Chazallon C, Meyer L, Trafojer UMT, Metsvaht T, Fournier I, Sharland M, Heath P, Standing JF; NeoMero Consortium.

J Antimicrob Chemother. 2018 Jul 1;73(7):1908-1916. doi: 10.1093/jac/dky128.

41.

Pharmacokinetic-Pharmacodynamic Modeling in Pediatric Drug Development, and the Importance of Standardized Scaling of Clearance.

Germovsek E, Barker CIS, Sharland M, Standing JF.

Clin Pharmacokinet. 2019 Jan;58(1):39-52. doi: 10.1007/s40262-018-0659-0. Review. Erratum in: Clin Pharmacokinet. 2018 Dec 17;:.

42.

Point prevalence surveys of antimicrobial use among eight neonatal intensive care units in India: 2016.

Gandra S, Alvarez-Uria G, Murki S, Singh SK, Kanithi R, Jinka DR, Chikkappa AK, Subramanian S, Sharma A, Dharmapalan D, Kandraju H, Vasudevan AK, Tunga O, Akula A, Hsia Y, Sharland M, Laxminarayan R.

Int J Infect Dis. 2018 Jun;71:20-24. doi: 10.1016/j.ijid.2018.03.017. Epub 2018 Mar 30.

43.

High Rates of Prescribing Antimicrobials for Prophylaxis in Children and Neonates: Results From the Antibiotic Resistance and Prescribing in European Children Point Prevalence Survey.

Hufnagel M, Versporten A, Bielicki J, Drapier N, Sharland M, Goossens H; ARPEC Project Group .

J Pediatric Infect Dis Soc. 2019 May 11;8(2):143-151. doi: 10.1093/jpids/piy019.

PMID:
29579259
44.

Potential for reducing inappropriate antibiotic prescribing in English primary care.

Smieszek T, Pouwels KB, Dolk FCK, Smith DRM, Hopkins S, Sharland M, Hay AD, Moore MV, Robotham JV.

J Antimicrob Chemother. 2018 Feb 1;73(suppl_2):ii36-ii43. doi: 10.1093/jac/dkx500.

45.

Unavailability of old antibiotics threatens effective treatment for common bacterial infections.

Tängdén T, Pulcini C, Aagaard H, Balasegaram M, Hara GL, Nathwani D, Sharland M, Theuretzbacher U, Cars O.

Lancet Infect Dis. 2018 Mar;18(3):242-244. doi: 10.1016/S1473-3099(18)30075-6. No abstract available. Erratum in: Lancet Infect Dis. 2018 Feb 28;:.

PMID:
29485082
46.

Classifying antibiotics in the WHO Essential Medicines List for optimal use-be AWaRe.

Sharland M, Pulcini C, Harbarth S, Zeng M, Gandra S, Mathur S, Magrini N; 21st WHO Expert Committee on Selection and Use of Essential Medicines.

Lancet Infect Dis. 2018 Jan;18(1):18-20. doi: 10.1016/S1473-3099(17)30724-7. Epub 2017 Dec 20. No abstract available.

PMID:
29303731
47.

Evaluating Safety Reporting in Paediatric Antibiotic Trials, 2000-2016: A Systematic Review and Meta-Analysis.

Pansa P, Hsia Y, Bielicki J, Lutsar I, Walker AS, Sharland M, Folgori L.

Drugs. 2018 Feb;78(2):231-244. doi: 10.1007/s40265-017-0850-x.

PMID:
29218501
48.

Urinary Tract Infection Antibiotic Trial Study Design: A Systematic Review.

Basmaci R, Vazouras K, Bielicki J, Folgori L, Hsia Y, Zaoutis T, Sharland M.

Pediatrics. 2017 Dec;140(6). pii: e20172209. doi: 10.1542/peds.2017-2209. Review.

49.

Congenital Cytomegalovirus: A European Expert Consensus Statement on Diagnosis and Management.

Luck SE, Wieringa JW, Blázquez-Gamero D, Henneke P, Schuster K, Butler K, Capretti MG, Cilleruelo MJ, Curtis N, Garofoli F, Heath P, Iosifidis E, Klein N, Lombardi G, Lyall H, Nieminen T, Pajkrt D, Papaevangelou V, Posfay-Barbe K, Puhakka L, Roilides E, Rojo P, Saavedra-Lozano J, Shah T, Sharland M, Saxen H, Vossen ACTM; ESPID Congenital CMV Group Meeting, Leipzig 2015.

Pediatr Infect Dis J. 2017 Dec;36(12):1205-1213. doi: 10.1097/INF.0000000000001763. Review. No abstract available.

PMID:
29140947
50.

Surveillance for control of antimicrobial resistance.

Tacconelli E, Sifakis F, Harbarth S, Schrijver R, van Mourik M, Voss A, Sharland M, Rajendran NB, Rodríguez-Baño J; EPI-Net COMBACTE-MAGNET Group.

Lancet Infect Dis. 2018 Mar;18(3):e99-e106. doi: 10.1016/S1473-3099(17)30485-1. Epub 2017 Nov 5. Review.

PMID:
29102325

Supplemental Content

Loading ...
Support Center